Antiviral Drugs in Respiratory Infections PDF
Document Details
Uploaded by EntertainingFunction6223
Gulf Medical University, Ajman
Tags
Summary
This document provides an overview of antiviral drugs used to treat respiratory infections such as influenza, COVID-19, and RSV. It discusses different types of respiratory viruses, symptoms, treatments, and dosages.
Full Transcript
Antiviral Drugs in Respiratory Infections Types of Respiratory Viral Infections: Influenza Virus (Flu) Type A & B are most commonly responsible for seasonal outbreaks. Symptoms: Fever, cough, sore throat Coronaviruses SARS-CoV-2 - causative agent/cause of COVID-19...
Antiviral Drugs in Respiratory Infections Types of Respiratory Viral Infections: Influenza Virus (Flu) Type A & B are most commonly responsible for seasonal outbreaks. Symptoms: Fever, cough, sore throat Coronaviruses SARS-CoV-2 - causative agent/cause of COVID-19 Treatment For Influenza: Antiviral drugs like neuraminidase inhibitors: Drug names ending with mivir like- Oseltamivir, zanamivir, peramivir. Endonuclease inhibitor: Only Bolaxavir. It is used for the treatment of uncomplicated influenza in patients ≥ 12 years old. Dosage: A single dose of 40 mg or 80 mg based on body weight For RSV: Antiviral drugs like Ribavirin and Palivizumab. For COVID-19: Drug names ending with vir (not mivir REMEMBER!!) like Remdesivir, Molnupiravir, and Paxlovid Oseltamivir (Tamiflu) is the first-line treatment for uncomplicated influenza. Zanamivir is inhaled formulation, and it is not recommended to patients with respiratory conditions like asthma or COPD.